Pneumagen
1 follower
‌
Pneumagen develops glycan targeted carbohydrate binding modules (CBMs) for respiratory tract infections ) and cancer.
Industries
+1
Headquarters
Employees
Links
Org chart
Douglas Thomson
Chief Executive Officer
Douglas Thomson
Collapse
